Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Walk-Through Survey Report at Oral Contraceptive Manufacturing Operations at Ortho Pharmaceutical Corporation, Raritan New Jersey.

Authors
Anonymous
Source
NIOSH 1979 Jun:13 pages
Link
NIOSHTIC No.
00111345
Abstract
Worker exposure to estrogens were studied at the Ortho Pharmaceutical Corporation (SIC-2834) in Raritan, New Jersey, on June 20, 1978. The company was under consideration for inclusion in a NIOSH study of the health effects of occupational estrogen exposure. Approximately 40 of the employees at the facility were assigned to the estrogen processing area. The company maintained a safety and industrial hygiene program, and a medical program. Personnel records provided demographic data, department assignments, and absence reports. Symptoms of estrogen exposure have not been reported among processing technicians since 1976. Work categories with the greatest potential for estrogen exposure were processing technicians, packaging area operators, quality assurance inspectors or laboratory technicians, and maintenance workers. The authors conclude that this workforce should not be included in the epidemiological study since all personnel records are destroyed 7 years after employee termination. In addition, only a relatively small number of employees are exposed to the estrogens, women are excluded from the production area, and the exposure period is relatively short.
Keywords
NIOSH-Author; NIOSH-Survey; Field-Study; Region-2; Hormones; Workplace-studies; Industrial-health-programs; IWS-85-14;
Publication Date
19790628
Fiscal Year
1979
NTIS Accession No.
PB82-152281
NTIS Price
A03
Identifying No.
IWS-85-14
NIOSH Division
DSHEFS;
SIC Code
2834;
Source Name
NIOSH, Industry-wide Studies Branch, Division of Surveillance, Hazard Evaluations and Field Studies, Cincinnati, Ohio, 13 pages
State
NJ; OH;
TOP